CANDEL THERAPEUTICS INC. - COMMON STOCK

9.0500

14-February-25 15:45:00

15 minutes delayed

Stocks

+0.2300

+2.61%

Today's range

8.8600 - 9.2000

ISIN

N/A

Source

NASDAQ

Candel Therapeutics Announces Presentations of Key Clinical Data at AdMeTech and European Association of Neuro-Oncology Conferences in September 2021

09 Sep 2021 07:00:03 By Nasdaq GlobeNewswire
Candel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights

08 Sep 2021 07:00:03 By Nasdaq GlobeNewswire
Candel Therapeutics Completes Enrollment in Phase 3 Clinical Trial of CAN-2409 in Combination with Valacyclovir for the Treatment of Intermediate-High Risk Localized Prostate Cancer

07 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
Candel Therapeutics Announces Closing of Initial Public Offering, Including the Partial Exercise of Underwriters’ Option

17 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
Candel Therapeutics Announces Pricing of Initial Public Offering

26 Jul 2021 20:05:38 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.